- ICH GCP
- US Clinical Trials Registry
- Researchers
- Canada
- Polycythemia Vera
Medical specialists from Canada tagged as investigators in clinical trials studying Polycythemia Vera
Total 5 results
-
Elena LiewSeen in:
- Alberta, Edmonton, University Of Alberta Hospital
Trials:- NCT04603495 (Principal Investigator)
-
Natasha SzuberSeen in:
- Montréal, Hopital Maisonneuve-Rosemont
Trials:- NCT04603495 (Principal Investigator)
-
Pierre VilleneuveSeen in:
- Montréal, Hopital Maisonneuve-Rosemont
- Ottawa, The Ottawa Hospital General Campus
Trials:- NCT04603495 (Principal Investigator)
-
Shireen Sirhan, MDSeen in:
- Quebec, Montréal, Jewish General Hospital
Trials:- NCT04603495 (Principal Investigator)
-
Sonia CerquozziSeen in:
- Alberta, Calgary, Tom Baker Cancer Centre
Trials:- NCT04603495 (Principal Investigator)
Clinical Trials on Polycythemia Vera
-
PharmaEssentia Japan K.K.RecruitingPolycythemia Vera (PV)Japan
-
Novartis PharmaceuticalsCompletedPolycythemia Vera (PV)United States
-
PharmaEssentia Japan K.K.Recruiting
-
PharmaEssentia Japan K.K.CompletedPolycythemia Vera (PV)Japan
-
Ionis Pharmaceuticals, Inc.RecruitingPhlebotomy Dependent Polycythemia VeraUnited States, Canada, Hungary, United Kingdom, Australia, Poland
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Celgene; The Leukemia and Lymphoma SocietyWithdrawnPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis PhaseUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom